Yunnan Baiyao Group Co Ltd is engaged in the manufacturing and marketing of medicines, which includes herbal products, daily health products, raw medicine, drug classics and among others.
1993
3.5K+
LTM Revenue $5.7B
LTM EBITDA $789M
$12.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Yunnan Baiyao Group has a last 12-month revenue (LTM) of $5.7B and a last 12-month EBITDA of $789M.
In the most recent fiscal year, Yunnan Baiyao Group achieved revenue of $5.6B and an EBITDA of $841M.
Yunnan Baiyao Group expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Yunnan Baiyao Group valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $5.7B | XXX | $5.6B | XXX | XXX | XXX |
Gross Profit | $1.6B | XXX | $1.6B | XXX | XXX | XXX |
Gross Margin | 28% | XXX | 28% | XXX | XXX | XXX |
EBITDA | $789M | XXX | $841M | XXX | XXX | XXX |
EBITDA Margin | 14% | XXX | 15% | XXX | XXX | XXX |
EBIT | $739M | XXX | $662M | XXX | XXX | XXX |
EBIT Margin | 13% | XXX | 12% | XXX | XXX | XXX |
Net Profit | $689M | XXX | $659M | XXX | XXX | XXX |
Net Margin | 12% | XXX | 12% | XXX | XXX | XXX |
Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Yunnan Baiyao Group's stock price is CNY 56 (or $8).
Yunnan Baiyao Group has current market cap of CNY 101B (or $14.0B), and EV of CNY 87.7B (or $12.2B).
See Yunnan Baiyao Group trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$12.2B | $14.0B | XXX | XXX | XXX | XXX | $0.39 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Yunnan Baiyao Group has market cap of $14.0B and EV of $12.2B.
Yunnan Baiyao Group's trades at 2.2x EV/Revenue multiple, and 14.5x EV/EBITDA.
Equity research analysts estimate Yunnan Baiyao Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Yunnan Baiyao Group has a P/E ratio of 20.3x.
See valuation multiples for Yunnan Baiyao Group and 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $14.0B | XXX | $14.0B | XXX | XXX | XXX |
EV (current) | $12.2B | XXX | $12.2B | XXX | XXX | XXX |
EV/Revenue | 2.1x | XXX | 2.2x | XXX | XXX | XXX |
EV/EBITDA | 15.4x | XXX | 14.5x | XXX | XXX | XXX |
EV/EBIT | 16.5x | XXX | 18.4x | XXX | XXX | XXX |
EV/Gross Profit | 7.7x | XXX | n/a | XXX | XXX | XXX |
P/E | 20.3x | XXX | 21.2x | XXX | XXX | XXX |
EV/FCF | 20.1x | XXX | 24.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialYunnan Baiyao Group's last 12 month revenue growth is 5%
Yunnan Baiyao Group's revenue per employee in the last FY averaged $1.6M, while opex per employee averaged $0.3M for the same period.
Yunnan Baiyao Group's rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Yunnan Baiyao Group's rule of X is 27% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Yunnan Baiyao Group and other 12K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | 5% | XXX | 5% | XXX | XXX | XXX |
EBITDA Margin | 14% | XXX | 15% | XXX | XXX | XXX |
EBITDA Growth | 11% | XXX | 8% | XXX | XXX | XXX |
Rule of 40 | 18% | XXX | 20% | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | 27% | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $1.6M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.3M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | 8% | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | 1% | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 16% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Yunnan Baiyao Group acquired XXX companies to date.
Last acquisition by Yunnan Baiyao Group was XXXXXXXX, XXXXX XXXXX XXXXXX . Yunnan Baiyao Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free TrialWhen was Yunnan Baiyao Group founded? | Yunnan Baiyao Group was founded in 1993. |
Where is Yunnan Baiyao Group headquartered? | Yunnan Baiyao Group is headquartered in China. |
How many employees does Yunnan Baiyao Group have? | As of today, Yunnan Baiyao Group has 3.5K+ employees. |
Who is the CEO of Yunnan Baiyao Group? | Yunnan Baiyao Group's CEO is Mr. Ming Dong. |
Is Yunnan Baiyao Group publicy listed? | Yes, Yunnan Baiyao Group is a public company listed on SHE. |
What is the stock symbol of Yunnan Baiyao Group? | Yunnan Baiyao Group trades under 000538 ticker. |
When did Yunnan Baiyao Group go public? | Yunnan Baiyao Group went public in 1993. |
Who are competitors of Yunnan Baiyao Group? | Similar companies to Yunnan Baiyao Group include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
What is the current market cap of Yunnan Baiyao Group? | Yunnan Baiyao Group's current market cap is $14.0B |
What is the current revenue of Yunnan Baiyao Group? | Yunnan Baiyao Group's last 12 months revenue is $5.7B. |
What is the current revenue growth of Yunnan Baiyao Group? | Yunnan Baiyao Group revenue growth (NTM/LTM) is 5%. |
What is the current EV/Revenue multiple of Yunnan Baiyao Group? | Current revenue multiple of Yunnan Baiyao Group is 2.1x. |
Is Yunnan Baiyao Group profitable? | Yes, Yunnan Baiyao Group is EBITDA-positive (as of the last 12 months). |
What is the current EBITDA of Yunnan Baiyao Group? | Yunnan Baiyao Group's last 12 months EBITDA is $789M. |
What is Yunnan Baiyao Group's EBITDA margin? | Yunnan Baiyao Group's last 12 months EBITDA margin is 14%. |
What is the current EV/EBITDA multiple of Yunnan Baiyao Group? | Current EBITDA multiple of Yunnan Baiyao Group is 15.4x. |
What is the current FCF of Yunnan Baiyao Group? | Yunnan Baiyao Group's last 12 months FCF is $605M. |
What is Yunnan Baiyao Group's FCF margin? | Yunnan Baiyao Group's last 12 months FCF margin is 11%. |
What is the current EV/FCF multiple of Yunnan Baiyao Group? | Current FCF multiple of Yunnan Baiyao Group is 20.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.